Press Releases

Schulman IRB Partners with iMedRIS to Develop IBC Technology

Date:Apr 5, 2017
Publication:Schulman IRB Partners with iMedRIS to Develop IBC Technology

Durham, NC and Redlands, CA: Schulman IRB, the industry-leading independent IRB in customer service and technology, announced today that iMedRIS Data Corporation, the fastest growing technology provider for optimizing research compliance and administration software, is developing the technology to power Schulman’s forthcoming institutional biosafety committee (IBC) service.

IBC clients and committee members will work from the same iMedRIS-developed platform, reducing duplicate data entry and the potential for errors while providing users with access to real-time information throughout the review process.

“We looked at a lot of options, and in the end we determined iMedRIS simply offers the best IBC software available,” said Daniel Eisenman, Biosafety Officer at Schulman IRB. “We’re able to easily customize the technology to our clients’ and committee members’ needs, and the system integrates well with our existing systems.”

For research involving human gene transfer (also known as gene therapy research), NIH Guidelines require a thorough risk assessment be performed by an IBC, along with institutional review board (IRB) review, for clinical trials to ensure the risks are identified and adequately mitigated.

Schulman’s forthcoming commercial IBC service will provide an independent option for research sponsors and institutions required to establish IBCs. The service will launch in the spring of 2017.

About Schulman IRB
Schulman IRB has been a leader in the protection of human research participants in the U.S., Puerto Rico and Canada since 1983. Schulman offers thorough, timely IRB review services – including dedicated review capabilities for all phases of research across all therapeutic areas – to clinical trial sponsors, CROs, investigators and institutions. Schulman also provides global consulting services in clinical quality assurance (CQA) and human research protections (HRP), and its commercial institutional biosafety committee (IBC) service will launch in Spring 2017. Fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), Schulman has an unparalleled clean audit history with the Food and Drug Administration (FDA).

About iMedRIS
iMedRIS has rapidly grown to become the leading research software solutions due to its singular focus on the success and satisfaction of its clients. The iRIS architecture, known for its flexibility and efficiency, caters solely to each institution’s requirements and the diverse business practices that follow. The iRIS™ Software empowers researchers to be more accurate and efficient through its scalable configurations and ease of implementation. Through iRIS™, iMedRIS has established its position as the fastest growing small business within the industry and has emerged as the preferred Integrated Research Information Software provider.

iMedRIS offers over 15 years of experience in the Research Administration field and is dedicated to advancing the research community with its state of the art software and enhanced integrated research programs.

Schulman IRB and iMedRIS Join Forces to Offer Integrated Services

Date:Nov 15, 2016
Publication:Cincinnati, OH and Redlands, CA: Schulman IRB, the industry-leading central IRB for customer service and technology, and iMedRIS Data Corporation, the fastest growing technology provider for optimizing research compliance and administration software, are pleased to announce their partnership to provide research organizations integrated technology, consulting and IRB review services.

Rather than contracting with multiple disparate service providers, research organizations and institutions can now work with a single organization for IRB review services, research management technology, and good clinical practice (GCP) and human research protections (HRP) consulting services.

“This partnership offers unparalleled service integration for ultimate ease of use,” said Michael Woods, President and CEO at Schulman IRB. “Schulman is delighted to now be able to offer clients the industry’s most flexible and user friendly research management tools available.”

“iMedRIS and Schulman share the same high standards of customer service and support, and we are excited to share Schulman’s services with our clients,” said William Schroeder, CEO at iMedRIS. “This represents two of the research community’s most trusted partners coming together to provide an integrated service package of unprecedented opportunities.”

This integration reflects the first phase in iMedRIS’ and Schulman IRB’s partnership. The two organizations will continue to evaluate their service offerings to find additional ways that clients can benefit from the collaboration.

About Schulman IRB
Schulman IRB has been a leader in the protection of human research participants in the U.S., Puerto Rico and Canada since 1983. Schulman offers thorough, timely IRB review services –including dedicated review capabilities for all phases of research across all therapeutic areas –to clinical trial sponsors, CROs, investigators and institutions. Schulman also provides global consulting services through its Provision Research Compliance Services division, offering comprehensive solutions to maximize the protection of human subjects and improve overall quality standards for clinical studies and data integrity. Fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), Schulman has an unparalleled clean audit history with the Food and Drug Administration (FDA).

About iMedRIS
iMedRIS has rapidly grown to become the leading research software solutions due to its singular focus on the success and satisfaction of its clients. The iRIS architecture, known for its flexibility and efficiency, caters solely to each institution’s requirements and the diverse business practices that follow. The iRIS™ Software empowers researchers to be more accurate and efficient through its scalable configurations and ease of implementation. Through iRIS™, iMedRIS has established its position as the fastest growing small business within the industry and has emerged as the preferred Integrated Research Information Software provider.

iMedRIS offers over 15 years of experience in the Research Administration field and is dedicated to advancing the research community with its state of the art software and enhanced integrated research programs.

Government Defense Health Client

Date:Apr 25, 2015
Publication:iMedRIS Data Corporation is pleased to announce that in conjunction with Aderas Inc. our Defense Health Client has successfully implemented its “Rapid Go-Live Implementation” of the EIRB project, providing the government research network with the tools necessary to conduct research on the iRIS™ system ensuring worldwide compliance oversight and streamlined operations for researchers.

Late last year, iMedRIS announced that a large Defense Health Client selected iRIS™ as its preferred solution to satisfy their need for an Electronic Institutional Review Board (EIRB) system. iMedRIS has partnered with Reston, Virginia based Aderas Inc. to provide the EIRB solution to the government for use within the Defense Health Client’s research network. iMedRIS Data Corporation provides innovative software that optimizes research administration and compliance objectives for researchers in the form of an integrated research information system called iRIS™. The new system will be used by the government across the world in hundreds of research sites and by its thousands of researchers in order to capture all record keeping, compliance, and regulatory requirements associated with the government’s research and review board processes.

Recognizing the sophisticated and complex research program and the significance of their work, iMedRIS contracted with Aderas Inc. to implement and provide an integrated research administration software suite comprising of IRB, IBC, IACUC, Scientific Review, and Radiation Safety components to fully encompass the needs of Defense Health Agency’s research community.

With the introduction of iRIS™ and iMedRIS’ partnership with Aderas Inc., the Defense Health Client will have the confidence that they can satisfy all of their compliance, regulatory and internal reporting needs within a unified system across all of their research sites regardless of their geographical location. Defense Health Clients can now conduct research with confidence, knowing that iRIS™ will enhance and streamline their research through the management of data, user accounts, and Institutional Review Boards.

- William Schroeder, CEO of iMedRIS Data Corporation is honored to be awarded the project and oversee its successful implementation: “We are delighted to welcome the ‘Defense Health Client’ into the iMedRIS family. I have spent 15 years investing in the development of our iRIS™ Compliance & Safety software modules. To receive recognition from the government through this award and successful implementation is a great achievement and a testament to the dedication my incredible staff”